How HBO’s Harry Potter series channels the cinematic approach of earlier films
HBO's upcoming Harry Potter series channels the cinematic approach of the earlier films through several deliberate creative choices: by investing in...
Category Series A
Series A funding insights
How a €15 billion European initiative targets the venture funding gap
Europe's persistent venture funding gap—where startups outside major hubs struggle to access capital compared to their U.S.
How a leading MVP contender redefines what valuable really means
A leading MVP contender—a startup that's built and scaling a Minimum Viable Product to early success—redefines value not as raw user acquisition or...
How baseball’s brightest star is discovering a purpose beyond winning awards
Baseball's highest earners are increasingly discovering that trophies, All-Star selections, and record-breaking seasons don't answer the deeper question:...
Can better month-end processes drive retention? A finance leader explains how
Yes—better month-end processes can meaningfully drive retention in finance teams, and the research backs this up.
Why a 2000s music group faced internal conflict over health policy views
Internal conflict within creative teams often stems not from artistic differences but from fundamental disagreements about organizational values and...
How a custom-built hybrid car merges classic design with modern performance
A custom-built hybrid car merges classic design with modern performance by retrofitting or reimagining vintage vehicles with contemporary electric or...
How a hospitality entrepreneur built a lasting legacy in Irish nightlife
A hospitality entrepreneur builds a lasting legacy in Irish nightlife by establishing a distinctive brand identity, nurturing deep community connections,...
Why a music scene influencer’s journey revealed the entertainment industry’s dangers
The dangers facing music scene influencers aren't always visible in the metrics. They emerge when an FTC investigator shows up, when a brand contract...
Did Pharmaceutical Shareholders Get a Fair Price in Acquisition?
In 2025 and early 2026, pharmaceutical shareholders have received notably favorable prices in major acquisitions, with deal premiums ranging from 24% to...